Telmisartan Market 2027 By Product, Application and Geography | The Insight Partners

Telmisartan Market to 2027 - Global Analysis and Forecasts Indication (Hypertension, Cardiac Arrest, Stroke); Composition (Single, Combinational); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00005565 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for treatment of hypertension, stroke management and cardiac arrest. Telmisartan is available in different strengths tablets in generic forms and under trade name Micardis. Telmisartan also has its side effects that includes dizziness, lightheadedness, cough, sinus pain and others.

MARKET DYNAMICS
The global Telmisartan market is expected to grow in upcoming years. Factors driving the growth of market are increasing prevalence of high blood pressure, increase in incidences of chronic diseases such as diabetes, growth in geriatric population and others. On the other hand rise on approval for abbreviated new drug application (ANDA) for manufacturing of generic telmisartan tablets is expected to offer growth opportunities in telmisartan market.

MARKET SCOPE
The "Global Telmisartan Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Telmisartan market with detailed market segmentation by indication, composition, distribution channel and geography. The global Telmisartan market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Telmisartan markets is segmented on the basis of indication, composition and distribution channel. Based on indication, the market is segmented as hypertension, cardiac arrest and stroke. Based on composition the Telmisartan market is segmented into single and combinational. On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Telmisartan market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Telmisartan market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Telmisartan market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Telmisartan market in these regions.

MARKET PLAYERS
The reports cover key developments in the Telmisartan market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Telmisartan market are anticipated to lucrative growth opportunities in the future with the rising demand for Telmisartan in the global market. Below mentioned is the list of few companies engaged in the Telmisartan market.

The report also includes the profiles of key Telmisartan market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Mylan N.V.
  • Hikma Pharmaceuticals PLC
  • Exelan Pharmaceuticals, Inc.
  • Macleods Pharmaceuticals Ltd.
  • Zydus Pharmaceuticals, Inc.
  • Torrent Pharmaceuticals Ltd.
  • Jubilant Cadista.
  • Aurobindo Pharma.
  • Solco Healthcare
  • Sandoz International GmbH
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Telmisartan Market - By Indication
1.3.2 Telmisartan Market - By Composition
1.3.3 Telmisartan Market - By Distribution Channel
1.3.4 Telmisartan Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TELMISARTAN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. TELMISARTAN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TELMISARTAN MARKET - GLOBAL MARKET ANALYSIS
6.1. TELMISARTAN - GLOBAL MARKET OVERVIEW
6.2. TELMISARTAN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. TELMISARTAN MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. HYPERTENSION
7.3.1. Overview
7.3.2. Hypertension Market Forecast and Analysis
7.4. CARDIAC ARREST
7.4.1. Overview
7.4.2. Cardiac Arrest Market Forecast and Analysis
7.5. STROKE
7.5.1. Overview
7.5.2. Stroke Market Forecast and Analysis
8. TELMISARTAN MARKET - REVENUE AND FORECASTS TO 2027 - COMPOSITION
8.1. OVERVIEW
8.2. COMPOSITION MARKET FORECASTS AND ANALYSIS
8.3. SINGLE
8.3.1. Overview
8.3.2. Single Market Forecast and Analysis
8.4. COMBINATIONAL
8.4.1. Overview
8.4.2. Combinational Market Forecast and Analysis
9. TELMISARTAN MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. TELMISARTAN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Telmisartan Market Overview
10.1.2 North America Telmisartan Market Forecasts and Analysis
10.1.3 North America Telmisartan Market Forecasts and Analysis - By Indication
10.1.4 North America Telmisartan Market Forecasts and Analysis - By Composition
10.1.5 North America Telmisartan Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Telmisartan Market Forecasts and Analysis - By Countries
10.1.6.1 United States Telmisartan Market
10.1.6.1.1 United States Telmisartan Market by Indication
10.1.6.1.2 United States Telmisartan Market by Composition
10.1.6.1.3 United States Telmisartan Market by Distribution Channel
10.1.6.2 Canada Telmisartan Market
10.1.6.2.1 Canada Telmisartan Market by Indication
10.1.6.2.2 Canada Telmisartan Market by Composition
10.1.6.2.3 Canada Telmisartan Market by Distribution Channel
10.1.6.3 Mexico Telmisartan Market
10.1.6.3.1 Mexico Telmisartan Market by Indication
10.1.6.3.2 Mexico Telmisartan Market by Composition
10.1.6.3.3 Mexico Telmisartan Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Telmisartan Market Overview
10.2.2 Europe Telmisartan Market Forecasts and Analysis
10.2.3 Europe Telmisartan Market Forecasts and Analysis - By Indication
10.2.4 Europe Telmisartan Market Forecasts and Analysis - By Composition
10.2.5 Europe Telmisartan Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Telmisartan Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Telmisartan Market
10.2.6.1.1 Germany Telmisartan Market by Indication
10.2.6.1.2 Germany Telmisartan Market by Composition
10.2.6.1.3 Germany Telmisartan Market by Distribution Channel
10.2.6.2 France Telmisartan Market
10.2.6.2.1 France Telmisartan Market by Indication
10.2.6.2.2 France Telmisartan Market by Composition
10.2.6.2.3 France Telmisartan Market by Distribution Channel
10.2.6.3 Italy Telmisartan Market
10.2.6.3.1 Italy Telmisartan Market by Indication
10.2.6.3.2 Italy Telmisartan Market by Composition
10.2.6.3.3 Italy Telmisartan Market by Distribution Channel
10.2.6.4 Spain Telmisartan Market
10.2.6.4.1 Spain Telmisartan Market by Indication
10.2.6.4.2 Spain Telmisartan Market by Composition
10.2.6.4.3 Spain Telmisartan Market by Distribution Channel
10.2.6.5 United Kingdom Telmisartan Market
10.2.6.5.1 United Kingdom Telmisartan Market by Indication
10.2.6.5.2 United Kingdom Telmisartan Market by Composition
10.2.6.5.3 United Kingdom Telmisartan Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Telmisartan Market Overview
10.3.2 Asia-Pacific Telmisartan Market Forecasts and Analysis
10.3.3 Asia-Pacific Telmisartan Market Forecasts and Analysis - By Indication
10.3.4 Asia-Pacific Telmisartan Market Forecasts and Analysis - By Composition
10.3.5 Asia-Pacific Telmisartan Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Telmisartan Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Telmisartan Market
10.3.6.1.1 Australia Telmisartan Market by Indication
10.3.6.1.2 Australia Telmisartan Market by Composition
10.3.6.1.3 Australia Telmisartan Market by Distribution Channel
10.3.6.2 China Telmisartan Market
10.3.6.2.1 China Telmisartan Market by Indication
10.3.6.2.2 China Telmisartan Market by Composition
10.3.6.2.3 China Telmisartan Market by Distribution Channel
10.3.6.3 India Telmisartan Market
10.3.6.3.1 India Telmisartan Market by Indication
10.3.6.3.2 India Telmisartan Market by Composition
10.3.6.3.3 India Telmisartan Market by Distribution Channel
10.3.6.4 Japan Telmisartan Market
10.3.6.4.1 Japan Telmisartan Market by Indication
10.3.6.4.2 Japan Telmisartan Market by Composition
10.3.6.4.3 Japan Telmisartan Market by Distribution Channel
10.3.6.5 South Korea Telmisartan Market
10.3.6.5.1 South Korea Telmisartan Market by Indication
10.3.6.5.2 South Korea Telmisartan Market by Composition
10.3.6.5.3 South Korea Telmisartan Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Telmisartan Market Overview
10.4.2 Middle East and Africa Telmisartan Market Forecasts and Analysis
10.4.3 Middle East and Africa Telmisartan Market Forecasts and Analysis - By Indication
10.4.4 Middle East and Africa Telmisartan Market Forecasts and Analysis - By Composition
10.4.5 Middle East and Africa Telmisartan Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Telmisartan Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Telmisartan Market
10.4.6.1.1 South Africa Telmisartan Market by Indication
10.4.6.1.2 South Africa Telmisartan Market by Composition
10.4.6.1.3 South Africa Telmisartan Market by Distribution Channel
10.4.6.2 Saudi Arabia Telmisartan Market
10.4.6.2.1 Saudi Arabia Telmisartan Market by Indication
10.4.6.2.2 Saudi Arabia Telmisartan Market by Composition
10.4.6.2.3 Saudi Arabia Telmisartan Market by Distribution Channel
10.4.6.3 U.A.E Telmisartan Market
10.4.6.3.1 U.A.E Telmisartan Market by Indication
10.4.6.3.2 U.A.E Telmisartan Market by Composition
10.4.6.3.3 U.A.E Telmisartan Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. TELMISARTAN MARKET, KEY COMPANY PROFILES
12.1. MYLAN N.V.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. HIKMA PHARMACEUTICALS PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. EXELAN PHARMACEUTICALS, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MACLEODS PHARMACEUTICALS LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ZYDUS PHARMACEUTICALS, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TORRENT PHARMACEUTICALS LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JUBILANT CADISTA.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AUROBINDO PHARMA.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SOLCO HEALTHCARE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANDOZ INTERNATIONAL GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Mylan N.V.
2. Hikma Pharmaceuticals PLC
3. Exelan Pharmaceuticals, Inc.
4. Macleods Pharmaceuticals Ltd.
5. Zydus Pharmaceuticals, Inc.
6. Torrent Pharmaceuticals Ltd.
7. Jubilant Cadista.
8. Aurobindo Pharma.
9. Solco Healthcare
10. Sandoz International GmbH